OuteiroLab

This is the official Twitter account of the Outeiro Lab, lead by Tiago Fleming Outeiro

[FENSRM @FENSRM]

Scientific Symposia #FRM2023☀️Algarve ☀️
S19: Molecular Mechanisms of Synaptopathy in Movement Disorders

🗣️@OuteiroLab
🇩🇪 @yourUMG

Let's discuss the molecular mechanisms underlying synaptic dysfunction in movement disorders
#Parkinson #Huntington

[Lauren Walker @Lauren_C_Walker]

Full house for @DanielErsk1ne @adpdnet! Really nice data showing differences between cells containing Lewy bodies and those without

[Tiago Outeiro @touteiro]

First day is over. Amazing to participate in a meeting in 3D again! Great talks today, and looking forward to more great Science tomorrow! #HEATNET_2021 #Heatnet21 @TSpiresJones @albertolleo @adpdnet @ScienceofPD @ARUK__Newcastle @UMGoe @DZNE_en

[Tiago Outeiro @touteiro]

2nd day is underway, with great talk by junior researchers. Well done everyone! #heatnet21 #heat_net2021 @TSpiresJones @albertolleo

[Tiago Outeiro @touteiro]

Always important to keep in mind parallel and alternative careers in science. Thank you @TSpiresJones and Lena from Life Science Factory in Goettingen @uniGoettingen @UMGoe @albertolleo

[Tiago Outeiro @touteiro]

Many in the community to take such a course! Being a reviewer is NOT about finding reasons to reject a paper or a grant, unlike many seem to think. It is about helping the authors achieve stronger and more meaningful studies and conclusions. @TSpiresJones #heatnet21 @ScienceofPD

[Tiago Outeiro @touteiro]

Registrations are open https://t.co/g5OtLLnmQP

[OuteiroLab @OuteiroLab]

Worth considering new ideas and hypothesis @adpdnet #ADPD2021

[Movement Disorders Journal @MDJ_Journal]

Filippou and Outeiro summarize the intriguing overlap between the genetics and cellular pathogenesis of #Parkinsons disease and melanoma. Their Viewpoint article highlights emerging therapeutic targets for PD derived from the world of cancer biology.

https://t.co/JoGVL8fpMy

[Tiago Outeiro @touteiro]

A great honor to be part of this team! @RuxandaLungu was the glue that brought us together! Let’s get the science done now! @OuteiroLab #ADPD2021 @adpdnet

[OuteiroLab @OuteiroLab]

#COVID19 #Covid_19 #Parkinsons

[Tiago Outeiro @touteiro]

Today is #WorldParkinsonsDay. The #COVIDー19 crisis, a tremendous challenge we never experienced before. But we cannot forget other major challenges we face - defeating #Parkinsons should continue to be part of our mission as well. Let’s not forget. #COVID19PT #Covid_19

[Tiago Outeiro @touteiro]

We @OuteiroLab and many around the world are working hard to learn and defeat #Parkinsons. #COVIDー19 #Covid_19 #COVID19 #COVID19PT should not distract us from this goal. We need to pay even more attention. #WorldParkinsonsDay

[Tiago Outeiro @touteiro]

Hsp27 reduces glycation‐induced toxicity and aggregation of alpha‐synuclein https://t.co/EpDky3NsHe

[AD/PD - Advances in Science & Therapy @adpdnet]

Let the final countdown begin! In only 5️⃣ days the #AATADPD 2020 Virtual Meeting will officially start! You can attend any lecture, whenever and wherever you want. No need to choose between parallel sessions - attend 100% of the talks at the Meeting.👉https://t.co/loXCuarmbp

[OuteiroLab @OuteiroLab]

This is commendable! Excellent work!

[Nicholas A. Christakis @NAChristakis]

But here’s the thing: once you’re immune to COVID19, you can go about your business. Immune people can move about & help restore our economy. As number of such people rises, it will also confer "herd immunity" to our population, by blocking viral transmission, helping us all! 31/

[Uni Göttingen @uniGoettingen]

Good morning! Today is International Day of Happiness. So don't forget to bring joy to yourselves and others during this time of crisis. Even if you have to use a sock puppet for it. 😆 #InternationalDayofHappiness

[OuteiroLab @OuteiroLab]

Beautiful work from Daniel Kaganovich and Triana Amen in our Department. Check out the cover ;)
https://t.co/8ughSRP1vu

[Tiago Outeiro @touteiro]

We should take action, together!
https://t.co/NC212nxkPr

[Tiago Outeiro @touteiro]

Let’s keep the discussion on the science. I have been working on Synuclein for more than 20 years, but we need to be open minded here. Incidental LB disease argues against GOF. I still think we need to design better experiments. And GOF goes well with LOF

[Tiago Outeiro @touteiro]

This is not about GOF or LOF... patients don’t care about this. The question is: what are the key experiments that might enable us to favor one theory over the other? Can we answer this? This is what the debate should be about, as far as I am concerned.